Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. - Slavin,S.; Naparstek,E.; Nagler,A.; Ackerstein,A.; Samuel,S.; Kapelushnik,J.; Brautbar,C.; Or,R. (Blood, 1996)